Nonaqueous Gel for the Transdermal Delivery of a DTPA Penta-ethyl Ester Prodrug

Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 2

Abstract

Diethylenetriamine pentaacetic acid penta-ethyl ester, designated as C2E5, was successfully incorporated into a nonaqueous gel for transdermal delivery. The thermal and rheological properties of a formulation containing 40% C2E5, 20% ethyl cellulose, and 40% Miglyol 840® prepared using the solvent evaporation method demonstrated that the gel had acceptable content uniformity and flow properties. In vitro studies showed that C2E5 was steadily released from the gel at a rate suitable for transdermal delivery. Topical application of the gel at a 200 mg C2E5/kg dose level in rats achieved significantly higher plasma exposures of several active metabolites compared with neat C2E5 oil at the same dose level. The results suggest that transdermal delivery of a chelator prodrug is an effective radionuclide decorporation strategy by delivering chelators to the circulation with a pharmacokinetic profile that is more consistent with the biokinetic profile of transuranic elements in contaminated individuals.

Authors and Affiliations

Yong Zhang, Matthew P. Sadgrove, Katsuhiko Sueda, Yu-Tsai Yang, Erik K. Pacyniak, John R. Kagel, Brenda A. Braun, William C. Zamboni, Russell J. Mumper, Michael Jay

Keywords

Related Articles

Critical ligand binding reagent preparation/selection: When specificity depends on reagents

Throughout the life cycle of biopharmaceutical products, bioanalytical support is provided using ligand binding assays to measure the drug product for pharmacokinetic, pharmacodynamic, and immunogenicity studies. The spe...

Specific Method Validation and Sample Analysis Approaches for Biocomparability Studies of Denosumab Addressing Method and Manufacture Site Changes

The online version of this article (doi:10.1208/s12248-012-9414-x) contains supplementary material, which is available to authorized users.

In Vitro Studies are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-Release Solid Oral Dosage Forms

Human pharmacokinetic in vivo studies are often presumed to serve as the “gold standard” to assess product bioequivalence (BE) of immediate-release (IR) solid oral dosage forms. However, when this general...

A Fast Method for Testing Covariates in Population PK/PD Models

The development of covariate models within the population modeling program like NONMEM is generally a time-consuming and non-trivial task. In this study, a fast procedure to approximate the change in objective function v...

Ligand-Binding Assay Development: What Do You Want to Measure Versus What You Are Measuring?

The analysis of biotherapeutics by ligand-binding assay (LBA) is associated with some unique challenges that are unlike those commonly encountered in chromatographic methods for chemically based small molecule drugs. Whi...

Download PDF file
  • EP ID EP681104
  • DOI  10.1208/s12248-013-9459-5
  • Views 43
  • Downloads 0

How To Cite

Yong Zhang, Matthew P. Sadgrove, Katsuhiko Sueda, Yu-Tsai Yang, Erik K. Pacyniak, John R. Kagel, Brenda A. Braun, William C. Zamboni, Russell J. Mumper, Michael Jay (2013). Nonaqueous Gel for the Transdermal Delivery of a DTPA Penta-ethyl Ester Prodrug. The AAPS Journal, 15(2), -. https://europub.co.uk/articles/-A-681104